Purchase of Medicines for the Health Center of the Municipality of Eucalyptus (2Nd Quarter)

BoliviaTenders notice for Purchase of Medicines for the Health Center of the Municipality of Eucalyptus (2Nd Quarter). The reference ID of the tender is 119954549 and it is closing on 02 Jun 2025.

100% Secure Payments

Tender Details

  • Country: Bolivia
  • Summary: Purchase of Medicines for the Health Center of the Municipality of Eucalyptus (2Nd Quarter)
  • BOT Ref No: 119954549
  • Deadline: 02 Jun 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 25-1411-00-1560085-1-1
  • Purchaser's Detail :
  • Purchaser : EUCALYPTUS MUNICIPAL AUTONOMOUS GOVERNMENT
    Fidel Fernando Beltran Guerra (telf 65418317)

  • Description :
  • The bidders are invited to buy medications for the health center of the municipality of Eucalyptus (2nd quarter)
    State: in force
    Entity: Autonomous Municipal Government of Eucalyptus
    Department: Oruro
    Publication date: May 28, 2025
    Modality: Minor Hiring - CM
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
BoliviaTenders Features

BoliviaTenders Features

Fresh and verified Tenders from Bolivia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Bolivia in your email inbox.

  Chat with us